We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
Cap. Flow
+$208M
Cap. Flow %
11.48%
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$9.12M
2
V icon
Visa
V
+$8.75M
3
MSI icon
Motorola Solutions
MSI
+$7.37M
4
EW icon
Edwards Lifesciences
EW
+$7.3M
5
CTXS
Citrix Systems Inc
CTXS
+$4.48M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.1M
2
BHC icon
Bausch Health
BHC
+$5.94M
3
DE icon
Deere & Co
DE
+$5.72M
4
STZ icon
Constellation Brands
STZ
+$4.59M
5
QCOM icon
Qualcomm
QCOM
+$4.55M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 13.48%
3 Consumer Discretionary 12.62%
4 Technology 11.4%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXAS
1701
DELISTED
Abraxas Petroleum Corp
AXAS
$29K ﹤0.01%
+1,295
New +$30.4K
ESI
1702
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
$28K ﹤0.01%
14,596
-40,355
-73% -$91.1K
PERI icon
1703
Perion Network
PERI
$386M
$25K ﹤0.01%
6,924
-41,392
-86% -$179K
HGT
1704
DELISTED
Hugoton Royalty Trust
HGT
$25K ﹤0.01%
10,751
NWBO
1705
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$9K ﹤0.01%
+14,739
New +$15.7K
AAT
1706
American Assets Trust
AAT
$1.42B
-14,187
Closed -$566K
ABBV icon
1707
AbbVie
ABBV
$431B
-9,412
Closed -$538K
ABR icon
1708
Arbor Realty Trust
ABR
$974M
-19,900
Closed -$135K
ACIC icon
1709
American Coastal Insurance
ACIC
$535M
-15,000
Closed -$288K
AEIS icon
1710
Advanced Energy
AEIS
$13.7B
-8,800
Closed -$306K
AFL icon
1711
Aflac
AFL
$63.7B
-18,404
Closed -$581K
AIR icon
1712
AAR Corp
AIR
$5.96B
-25,249
Closed -$588K
AKAM icon
1713
Akamai
AKAM
$17.9B
-11,622
Closed -$646K
AKBA icon
1714
Akebia Therapeutics
AKBA
$354M
-10,881
Closed -$98K
ALLE icon
1715
Allegion
ALLE
$14.1B
-11,320
Closed -$721K
ALTO icon
1716
Alto Ingredients
ALTO
$410M
-457,665
Closed -$2.14M
AN icon
1717
AutoNation
AN
$7.13B
-6,575
Closed -$307K
ANDE icon
1718
Andersons Inc
ANDE
$2.54B
-6,448
Closed -$203K
ANIK icon
1719
Anika Therapeutics
ANIK
$262M
-12,134
Closed -$543K
AOS icon
1720
A.O. Smith
AOS
$8.61B
-18,252
Closed -$696K
APO icon
1721
Apollo Global Management
APO
$76.8B
-52,242
Closed -$894K
APPF icon
1722
AppFolio
APPF
$7.07B
-36,790
Closed -$450K
ARCO icon
1723
Arcos Dorados Holdings
ARCO
$1.76B
-88,501
Closed -$323K
ARDX icon
1724
Ardelyx
ARDX
$1.24B
-13,300
Closed -$103K
ARES icon
1725
Ares Management
ARES
$32.2B
-29,707
Closed -$457K

Similar funds

GSA Capital Partners's Q2 2016 Portfolio in Review

As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.

GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.

  • GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
  • GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
  • GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
  • GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
  • GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
  • GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
  • GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.

Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.